Clinical Trial Update: Multi-dimensional Clinical and Pathophysiological Profiles of Patients With Functional Dyspepsia and Effect of Gut Microbiota Manipulation Using Rifaximin for Its Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating multidimensional profiles of functional dyspepsia and the effect of rifaximin gut microbiota manipulation for treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences | Conditions: Dyspepsia | Phase 2 | Status: UNKNOWN